Side-by-side comparison of AI visibility scores, market position, and capabilities
Generative AI platform for legal research, contract analysis, and due diligence trusted by AmLaw 100 firms. San Francisco CA, raised $300M+.
Harvey AI is one of the most prominent generative AI companies built specifically for the legal profession, providing large law firms, in-house legal teams, and professional services organizations with a powerful AI platform for legal research, contract analysis, regulatory review, due diligence, and legal drafting. Founded in 2022 and headquartered in San Francisco, Harvey has raised more than $300 million from investors including OpenAI Ventures, Sequoia Capital, and GV, achieving a valuation exceeding $1.5 billion and establishing itself as a category leader among legal AI companies.\n\nHarvey's platform is built on foundation models customized with legal domain expertise, enabling it to analyze complex legal documents, surface relevant precedents and statutory authorities, draft and revise contract provisions, and answer nuanced legal questions with a level of accuracy and context-awareness that general-purpose AI tools cannot match. The company has secured partnerships with a significant number of AmLaw 100 firms, global law firms, and major corporate legal departments, giving it both commercial scale and a network of sophisticated users whose feedback drives ongoing model improvement.\n\nHarvey differentiates from general-purpose AI tools through its investment in legal-specific model training, its enterprise security architecture — including options for private deployment — and its deep integrations with legal workflow tools, document management systems, and research databases. As generative AI adoption in law accelerates, Harvey is positioned at the top of a growing market of AI-native legal technology companies competing to become the operating system for the modern legal professional.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.